These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28760216)

  • 21. Post market surveillance in the german medical device sector - current state and future perspectives.
    Zippel C; Bohnet-Joschko S
    Health Policy; 2017 Aug; 121(8):880-886. PubMed ID: 28697849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Imaging Endpoints in Clinical Trials.
    Gillam LD; Leipsic J; Weissman NJ
    JACC Cardiovasc Imaging; 2017 Mar; 10(3):296-303. PubMed ID: 28279377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the Use of Real-World Evidence for Medical Devices: An Update From the National Evaluation System for Health Technology.
    Fleurence RL; Shuren J
    Clin Pharmacol Ther; 2019 Jul; 106(1):30-33. PubMed ID: 30888048
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical device vigilance at FDA.
    Gross TP; Kessler LG
    Stud Health Technol Inform; 1996; 28():17-24. PubMed ID: 10164091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The FDA's sentinel initiative--A comprehensive approach to medical product surveillance.
    Ball R; Robb M; Anderson SA; Dal Pan G
    Clin Pharmacol Ther; 2016 Mar; 99(3):265-8. PubMed ID: 26667601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical Device Manufacturing and Medical Device Reports (MDR).
    Arellano V
    Insight; 2009; 34(3):24-5. PubMed ID: 19708431
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical device surveillance world-wide.
    Badea C; Kolitsi Z; Pallikarakis N; Papapanagiotou A
    Stud Health Technol Inform; 1996; 28():157-74. PubMed ID: 10184634
    [No Abstract]   [Full Text] [Related]  

  • 28. The US Food and drug administration: drug information resource for formulary recommendations.
    Marchand HC; Ros BJ; Fine AM; Kremzner ME
    J Manag Care Pharm; 2012; 18(9):713-8. PubMed ID: 23206214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet).
    Zeitler EP; Al-Khatib SM; Drozda JP; Kessler LG; Kirtane AJ; Kong DF; Laschinger J; Marinac-Dabic D; Morice MC; Reed T; Sedrakyan A; Stein KM; Tcheng J; Krucoff MW;
    Am Heart J; 2016 Jan; 171(1):64-72.e1-2. PubMed ID: 26699602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Safe Medical Devices Act of 1990--FDA. Notice.
    Fed Regist; 1991 Apr; 56(66):14111-3. PubMed ID: 10111151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical device accident reporting: does it improve patient safety?
    Nobel JJ
    Stud Health Technol Inform; 1996; 28():29-35. PubMed ID: 10172828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
    Ronquillo JG; Zuckerman DM
    Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Vascular Implant Surveillance and Interventional Outcomes (VISION) Coordinated Registry Network: An effort to advance evidence evaluation for vascular devices.
    Tsougranis G; Eldrup-Jorgensen J; Bertges D; Schermerhorn M; Morales P; Williams S; Bloss R; Simons J; Deery SE; Scali S; Roche-Nagle G; Mureebe L; Mell M; Malas M; Pullin B; Stone DH; Malone M; Beck AW; Wang G; Marinac-Dabic D; Sedrakyan A; Goodney PP
    J Vasc Surg; 2020 Dec; 72(6):2153-2160. PubMed ID: 32442604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium.
    Sager PT; Seltzer J; Turner JR; Anderson JL; Hiatt WR; Kowey P; Prochaska JJ; Stockbridge N; White WB
    Am Heart J; 2015 Apr; 169(4):486-95. PubMed ID: 25819855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments.
    Fed Regist; 1993 Sep; 58(168):46514. PubMed ID: 10128334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How do regulatory agencies ensure the release of a safe medical device?
    Haggar B
    Clin Perform Qual Health Care; 1999; 7(2):100-3. PubMed ID: 10747561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.